Abstract:

The symptoms of Tamaka Shwasa, which are similar to those of bronchial asthma in contemporary medicine and are described in Ayurveda as a chronic Kapha-Vata dominating condition of the Pranavaha Srotas, include coughing, chest tightness, wheezing, and dyspnea. For symptomatic relief, current therapy mostly consists of corticosteroids and bronchodilators, however they sometimes result in long-term adverse effects and medication dependence. By means of detoxification (Shodhana), palliative herbal remedies (Shamana Chikitsa), dietary management, and lifestyle adjustment, Ayurveda, in contrast, takes a comprehensive approach to eliminate Ama (toxins), balance doshas, and enhance respiratory and immunological systems. This research is based on a comprehensive analysis of the literature from 2012 to 2025, which is bolstered by clinical data from traditional Ayurvedic texts and contemporary research sources including PubMed, Google Scholar, AYUSH, and WHO recommendations. In order to evaluate the effectiveness of treatments like Virechana, Nasya, and herbal formulations like Vasa Avaleha and Pipaladi Lehya, clinical trials, case studies, and observational data were examined using important metrics like Peak Expiratory Flow Rate (PEFR), Absolute Eosinophil Count (AEC), and overall symptomatic relief. In addition to improving respiratory function and lowering the frequency and intensity of asthma episodes, the research shows that Ayurvedic therapies significantly improve quality of life with few adverse effects. The findings imply that combining traditional treatments with Ayurvedic techniques might provide a better long-term and sustainable approach to managing Tamaka Shwasa, treating the disease's symptoms as well as its underlying cause.

Keywords:

Tamaka Shwasa, Bronchial Asthma, Ayurveda, Kapha-Vata Dosha, Pranavaha Srotas

Aim/Objectives

Methods